Tillotts’ Vision is based on four strategic pillars:
- Continue to position Tillotts as a leading international specialty pharmaceutical company with a network of affiliates in Europe and gastroenterology-focused partners throughout the world.
- Continue to offer “state-of-the-art” services and products for the treatment of diseases of the digestive system.
- Grow an innovative and well-balanced product portfolio from our own development as well as through in-licensing and selective acquisitions.
- Continue to position Tillotts as the preferred partner for GI-healthcare professionals and patients.